Effects of octylphenol on the expression of cell cycle-related genes and the growth of mesenchymal stem cells derived from human umbilical cord blood

Lee,Hye-Rim; Kim,Tae-Hee; Choi,Kelvin  J.; Choi,Kyung-Chul

doi:10.3892/ijmm.2013.1556

Effects of octylphenol on the expression of cell cycle-related genes and the growth of mesenchymal stem cells derived from human umbilical cord blood

Authors:
- Hye-Rim Lee
- Tae-Hee Kim
- Kelvin J. Choi
- Kyung-Chul Choi
View Affiliations

Affiliations: Laboratory of Veterinary Biochemistry and Immunology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 361-763, Republic of Korea, Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang University, Bucheon, Gyeonggi 420-767, Republic of Korea, Department of Chemistry, University of British Columbia, Vancouver, BC V6T 1Z1, Canada
Published online on: November 14, 2013 https://doi.org/10.3892/ijmm.2013.1556
Pages: 221-226

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Umbilical cord blood (UCB) is defined as blood that exists in the placenta and in the attached umbilical cord following childbirth. Cord blood is now used for research purposes as it contains mesenchymal stem cells (MSCs), multipotent stromal cells which have the ability to differentiate into a variety of cell types. Among endocrine disrupting chemicals (EDCs), octylphenol (OP) is one of the alkylphenols, which are widely used industrial chemicals; these chemicals cause a number of serious side-effects, such as reproductive abnormalities. In this study, we isolated human MSCs from UCB and demonstrate that cultured MSCs express the surface marker, CD34, but not CD105. We further examined the effects of OP on human UCB-derived MSCs following exposure to OP by cell proliferation assay, semi-quantitative RT-PCR and western blot analysis. The results revealed that the transcriptional and translational levels of cyclin D1 were increased, while the levels of p21 were suppressed in the MSCs treated with OP compared with the negative controls. This collapse of the regulation of the cell cycle may directly stimulate the growth of the MSCs under culture conditions. The results from the present study provide further insight into the effects of common EDCs on MSCs derived from human UCB. However, further studies are required to identify the signaling pathways which mediate the effects of EDCs on MSCs.

View Figures

View References

1	Wong CJ, Casper RF and Rogers IM: Epigenetic changes to human umbilical cord blood cells cultured with three proteins indicate partial reprogramming to a pluripotent state. Exp Cell Res. 316:927–939. 2010. View Article : Google Scholar : PubMed/NCBI
2	Kermani AJ, Fathi F and Mowla SJ: Characterization and genetic manipulation of human umbilical cord vein mesenchymal stem cells: potential application in cell-based gene therapy. Rejuvenation Res. 11:379–386. 2008. View Article : Google Scholar : PubMed/NCBI
3	Reddi AS, Kuppasani K and Ende N: Human umbilical cord blood as an emerging stem cell therapy for diabetes mellitus. Curr Stem Cell Res Ther. 5:356–361. 2010. View Article : Google Scholar : PubMed/NCBI
4	Han YF, Tao R, Sun TJ, Chai JK, Xu G and Liu J: Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods. Cytotechnology. 65:819–827. 2013. View Article : Google Scholar : PubMed/NCBI
5	Fonseka M, Ramasamy R, Tan BC and Seow HF: Human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) inhibit the proliferation of K562 (human erythromyeloblastoid leukaemic cell line). Cell Biol Int. 36:793–801. 2012. View Article : Google Scholar : PubMed/NCBI
6	Jung S, Sen A, Rosenberg L and Behie LA: Human mesenchymal stem cell culture: rapid and efficient isolation and expansion in a defined serum-free medium. J Tissue Eng Regen Med. 6:391–403. 2012. View Article : Google Scholar : PubMed/NCBI
7	Asari T, Furukawa K, Tanaka S, Kudo H, Mizukami H, Ono A, Numasawa T, Kumagai G, Motomura S, Yagihashi S and Toh S: Mesenchymal stem cell isolation and characterization from human spinal ligaments. Biochem Biophys Res Commun. 417:1193–1199. 2012. View Article : Google Scholar : PubMed/NCBI
8	Lechner V, Hocht B, Ulrichs K, Thiede A and Meyer T: Obtaining of mesenchymal progenitor cells from the human umbilical cord. Zentralbl Chir. 132:358–364. 2007.(In German).
9	Xu Y, Huang S, Ma K, Fu X, Han W and Sheng Z: Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton’s jelly: sweat gland cell-like differentiative capacity. J Tissue Eng Regen Med. 6:645–654. 2012.PubMed/NCBI
10	Kamolz LP, Kolbus A, Wick N, Mazal PR, Eisenbock B, Burjak S and Meissl G: Cultured human epithelium: human umbilical cord blood stem cells differentiate into keratinocytes under in vitro conditions. Burns. 32:16–19. 2006. View Article : Google Scholar : PubMed/NCBI
11	Hussain I, Magd SA, Eremin O and El-Sheemy M: New approach to isolate mesenchymal stem cell (MSC) from human umbilical cord blood. Cell Biol Int. 36:595–600. 2012. View Article : Google Scholar : PubMed/NCBI
12	Lee HR, Hwang KA, Park MA, Yi BR, Jeung EB and Choi KC: Treatment with bisphenol A and methoxychlor results in the growth of human breast cancer cells and alteration of the expression of cell cycle-related genes, cyclin D1 and p21, via an estrogen receptor-dependent signaling pathway. Int J Mol Med. 29:883–890. 2012.
13	Lee HR and Choi KC: 4-tert-Octylphenol stimulates the expression of cathepsins in human breast cancer cells and xenografted breast tumors of a mouse model via an estrogen receptor-mediated signaling pathway. Toxicology. 304:13–20. 2013. View Article : Google Scholar
14	Dang VH, Choi KC and Jeung EB: Estrogen receptors are involved in xenoestrogen induction of growth hormone in the rat pituitary gland. J Reprod Dev. 55:206–213. 2009. View Article : Google Scholar : PubMed/NCBI
15	Zhang X, Li Q, Li G, Wang Z and Yan C: Levels of estrogenic compounds in Xiamen Bay sediment, China. Mar Pollut Bull. 58:1210–1216. 2009. View Article : Google Scholar : PubMed/NCBI
16	Hamelin G, Charest-Tardif G, Krishnan K, Cyr D, Charbonneau M, Devine PJ, Haddad S, Cooke GM, Schrader T and Tardif R: Toxicokinetics of p-tert-octylphenol in male and female Sprague-Dawley rats after intravenous, oral, or subcutaneous exposures. J Toxicol Environ Health A. 72:541–550. 2009. View Article : Google Scholar : PubMed/NCBI
17	Kang NH, Hwang KA, Kim TH, Hyun SH, Jeung EB and Choi KC: Induced growth of BG-1 ovarian cancer cells by 17β-estradiol or various endocrine disrupting chemicals was reversed by resveratrol via downregulation of cell cycle progression. Mol Med Rep. 6:151–156. 2012.
18	Sharma VK, Anquandah GA, Yngard RA, Kim H, Fekete J, Bouzek K, Ray AK and Golovko D: Nonylphenol, octylphenol, and bisphenol-A in the aquatic environment: a review on occurrence, fate, and treatment. J Environ Sci Health A Tox Hazard Subst Environ Eng. 44:423–442. 2009. View Article : Google Scholar : PubMed/NCBI
19	Hwang KA, Park SH, Yi BR and Choi KC: Gene alterations of ovarian cancer cells expressing estrogen receptors by estrogen and bisphenol a using microarray analysis. Lab Anim Res. 27:99–107. 2011. View Article : Google Scholar : PubMed/NCBI
20	Park MA, Hwang KA, Lee HR, Yi BR, Jeung EB and Choi KC: Cell growth of BG-1 ovarian cancer cells is promoted by di-n-butyl phthalate and hexabromocyclododecane via upregulation of the cyclin D and cyclin-dependent kinase-4 genes. Mol Med Rep. 5:761–766. 2011.PubMed/NCBI
21	Jung EM, An BS, Yang H, Choi KC and Jeung EB: Biomarker genes for detecting estrogenic activity of endocrine disruptors via estrogen receptors. Int J Environ Res Public Health. 9:698–711. 2012. View Article : Google Scholar : PubMed/NCBI
22	Park SH, Kim KY, An BS, Choi JH, Jeung EB, Leung PC and Choi KC: Cell growth of ovarian cancer cells is stimulated by xenoestrogens through an estrogen-dependent pathway, but their stimulation of cell growth appears not to be involved in the activation of the mitogen-activated protein kinases ERK-1 and p38. J Reprod Dev. 55:23–29. 2009. View Article : Google Scholar
23	Fernandez-Sanjuan M, Rigol A, Sahuquillo A, Rodriguez-Cruz S and Lacorte S: Determination of alkylphenols and alkylphenol ethoxylates in sewage sludge: effect of sample pre-treatment. Anal Bioanal Chem. 394:1525–1533. 2009. View Article : Google Scholar : PubMed/NCBI
24	Rhee JS, Lee YM, Raisuddin S and Lee JS: Expression of R-ras oncogenes in the hermaphroditic fish Kryptolebias marmoratus, exposed to endocrine disrupting chemicals. Comp Biochem Physiol C Toxicol Pharmacol. 149:433–439. 2009. View Article : Google Scholar : PubMed/NCBI
25	Ajj H, Chesnel A, Pinel S, Plenat F, Flament S and Dumond H: An alkylphenol mix promotes seminoma derived cell proliferation through an ERalpha36-mediated mechanism. PLoS One. 8:e617582013. View Article : Google Scholar : PubMed/NCBI
26	Fu QL, Chow YY, Sun SJ, Zeng QX, Li HB, Shi JB, Sun YQ, Wen W, Tse HF, Lian Q and Xu G: Mesenchymal stem cells derived from human induced pluripotent stem cells modulate T-cell phenotypes in allergic rhinitis. Allergy. 67:1215–1222. 2012. View Article : Google Scholar PubMed/NCBI
27	Fossett E and Khan WS: Optimising human mesenchymal stem cell numbers for clinical application: a literature review. Stem Cells Int. 2012:4652592012. View Article : Google Scholar : PubMed/NCBI
28	Kim ES, Ahn SY, Im GH, Sung DK, Park YR, Choi SH, Choi SJ, Chang YS, Oh W, Lee JH and Park WS: Human umbilical cord blood-derived mesenchymal stem cell transplantation attenuates severe brain injury by permanent middle cerebral artery occlusion in newborn rats. Pediatr Res. 72:277–284. 2012. View Article : Google Scholar : PubMed/NCBI
29	Fickert S, Schroter-Bobsin U, Gross AF, Hempel U, Wojciechowski C, Rentsch C, Corbeil D and Günther KP: Human mesenchymal stem cell proliferation and osteogenic differentiation during long-term ex vivo cultivation is not age dependent. J Bone Miner Metab. 29:224–235. 2011. View Article : Google Scholar : PubMed/NCBI
30	Galindo LT, Filippo TR, Semedo P, Ariza CB, Moreira CM, Camara NO and Porcionatto MA: Mesenchymal stem cell therapy modulates the inflammatory response in experimental traumatic brain injury. Neurol Res Int. 2011:5640892011.PubMed/NCBI
31	Hafizi M, Atashi A, Bakhshandeh B, Kabiri M, Nadri S, Hosseini RH and Soleimani M: MicroRNAs as markers for neurally committed CD133⁺/CD34⁺ stem cells derived from human umbilical cord blood. Biochem Genet. 51:175–188. 2013. View Article : Google Scholar : PubMed/NCBI
32	Oodi A, Noruzinia M, Habibi Roudkenar M, Nikougoftar M, Soltanpour MS, Khorshidfar M and Amirizadeh N: Expression of P16 cell cycle inhibitor in human cord blood CD34⁺ expanded cells following co-culture with bone marrow-derived mesenchymal stem cells. Hematology. 17:334–340. 2012. View Article : Google Scholar : PubMed/NCBI